These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish. Gupta VA; Kawahara G; Myers JA; Chen AT; Hall TE; Manzini MC; Currie PD; Zhou Y; Zon LI; Kunkel LM; Beggs AH PLoS One; 2012; 7(8):e43794. PubMed ID: 22952766 [TBL] [Abstract][Full Text] [Related]
6. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle. Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075 [TBL] [Abstract][Full Text] [Related]
7. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy. Nguyen Q; Lim KRQ; Yokota T Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722 [TBL] [Abstract][Full Text] [Related]
8. Zhang D; Zhang Y; Zhang Y; Yi H; Wang Z; Wu R; He D; Wei G; Wei S; Hu Y; Deng J; Criswell T; Yoo J; Zhou Y; Atala A Tissue Eng Part A; 2017 Aug; 23(15-16):784-794. PubMed ID: 28463580 [TBL] [Abstract][Full Text] [Related]
9. Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy. Vishnudas VK; Miller JB Hum Mol Genet; 2009 Dec; 18(23):4467-77. PubMed ID: 19692349 [TBL] [Abstract][Full Text] [Related]
11. Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice. Aoki Y; Nagata T; Yokota T; Nakamura A; Wood MJ; Partridge T; Takeda S Hum Mol Genet; 2013 Dec; 22(24):4914-28. PubMed ID: 23882132 [TBL] [Abstract][Full Text] [Related]
12. Decellularized mice colons as models to study the contribution of the extracellular matrix to cell behavior and colon cancer progression. Alabi BR; LaRanger R; Shay JW Acta Biomater; 2019 Dec; 100():213-222. PubMed ID: 31562987 [TBL] [Abstract][Full Text] [Related]
13. Decellularized extracellular matrices derived from cultured cells at stepwise myogenic stages for the regulation of myotube formation. Hoshiba T; Yokoyama N Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118658. PubMed ID: 31978502 [TBL] [Abstract][Full Text] [Related]
14. Laminin-111 protein therapy after disease onset slows muscle disease in a mouse model of laminin-α2 related congenital muscular dystrophy. Barraza-Flores P; Bukovec KE; Dagda M; Conner BW; Oliveira-Santos A; Grange RW; Burkin DJ Hum Mol Genet; 2020 Aug; 29(13):2162-2170. PubMed ID: 32472139 [TBL] [Abstract][Full Text] [Related]
16. Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. Vilquin JT; Kinoshita I; Roy B; Goulet M; Engvall E; Tomé F; Fardeau M; Tremblay JP J Cell Biol; 1996 Apr; 133(1):185-97. PubMed ID: 8601607 [TBL] [Abstract][Full Text] [Related]
17. The absence of MyoD in regenerating skeletal muscle affects the expression pattern of basement membrane, interstitial matrix and integrin molecules that is consistent with delayed myotube formation. Huijbregts J; White JD; Grounds MD Acta Histochem; 2001 Oct; 103(4):379-96. PubMed ID: 11700944 [TBL] [Abstract][Full Text] [Related]
19. Fibronectin, laminin, type I, III and IV collagens in Duchenne's muscular dystrophy, congenital muscular dystrophies and congenital myopathies: an immunocytochemical study. Hantaï D; Labat-Robert J; Grimaud JA; Fardeau M Connect Tissue Res; 1985; 13(4):273-81. PubMed ID: 3161692 [TBL] [Abstract][Full Text] [Related]